67 related articles for article (PubMed ID: 22336225)
1. Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.
Lau AH; Lai HK; Yeung BH; Leung SL; Tsang SY; Wong YH; Wise H
Prostaglandins Leukot Essent Fatty Acids; 2012 Mar; 86(3):119-26. PubMed ID: 22336225
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling.
Lo RK; Liu AM; Wise H; Wong YH
Cell Signal; 2008 Nov; 20(11):2095-106. PubMed ID: 18755267
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.
Lo RK; Wise H; Wong YH
Cell Signal; 2006 Mar; 18(3):307-17. PubMed ID: 15979846
[TBL] [Abstract][Full Text] [Related]
4. The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells.
Shen HW; Chen YL; Chern CY; Kan WM
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):231-6. PubMed ID: 17481561
[TBL] [Abstract][Full Text] [Related]
5. RAD001-mediated STAT3 upregulation and megakaryocytic differentiation.
Su YC; Li SC; Peng HY; Ho YH; Chen LJ; Liao HF
Thromb Haemost; 2013 Mar; 109(3):540-9. PubMed ID: 23329056
[TBL] [Abstract][Full Text] [Related]
6. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
7. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins.
Schwaner I; Seifert R; Schultz G
Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455
[TBL] [Abstract][Full Text] [Related]
8. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G
Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294
[TBL] [Abstract][Full Text] [Related]
9. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
Schick BP; Thornton RD
Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells.
Dai W; Murphy MJ
Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382
[TBL] [Abstract][Full Text] [Related]
11. CDDO-Im is a stimulator of megakaryocytic differentiation.
Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
[TBL] [Abstract][Full Text] [Related]
12. Staurosporine induces megakaryocytic differentiation through the upregulation of JAK/Stat3 signaling pathway.
Peng HY; Liao HF
Ann Hematol; 2011 Sep; 90(9):1017-29. PubMed ID: 21331591
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells.
Cailleteau C; Liagre B; Battu S; Jayat-Vignoles C; Beneytout JL
Anal Biochem; 2008 Sep; 380(1):26-34. PubMed ID: 18549804
[TBL] [Abstract][Full Text] [Related]
14. Adherence of human erythroleukemia cells inhibits proliferation without inducing differentiation.
Molla A; Block MR
Cell Growth Differ; 2000 Feb; 11(2):83-90. PubMed ID: 10714764
[TBL] [Abstract][Full Text] [Related]
15. A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons.
Nakae K; Saito K; Iino T; Yamamoto N; Wakabayashi M; Yoshikawa S; Matsushima S; Miyashita H; Sugimoto H; Kiba A; Gupta J
J Pharmacol Exp Ther; 2005 Dec; 315(3):1136-42. PubMed ID: 16109742
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the human prostacyclin receptor gene in megakaryocytes: major roles for C/EBPδ and PU.1.
Keating GL; Turner EC; Kinsella BT
Biochim Biophys Acta; 2012 May; 1819(5):428-45. PubMed ID: 22381139
[TBL] [Abstract][Full Text] [Related]
17. Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3.
Harada Y; Ishii I; Hatake K; Kasahara T
Cancer Lett; 2012 Jun; 319(1):83-8. PubMed ID: 22210382
[TBL] [Abstract][Full Text] [Related]
18. Changes in protein sulfation in human erythroleukemia (HEL), CHRF-288-11, and K562 cells following treatment with dimethyl sulfoxide or phorbol 12-myristate 13-acetate.
Schick BP; Tang RP; Jacoby JA
Arch Biochem Biophys; 1995 Feb; 317(1):191-200. PubMed ID: 7872784
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of human NDR gene in megakaryocytic differentiation of erythroleukemia K562 cells.
Liu CC; Chou YL; Ch'ang LY
J Biomed Sci; 2004; 11(1):104-16. PubMed ID: 14730214
[TBL] [Abstract][Full Text] [Related]
20. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
